At Metagenics, we are committed to the development of products and programs that help deliver on our corporate mission of helping people achieve their genetic potential through nutrition.

To the research and development team at Metagenics this translates into integrating the historical use of foods and nutrients for disease prevention and treatment with the latest in the company's nutrigenomic research. Through the application of these concepts, and by clinically testing products at the Functional Medicine Research Center, (the research arm of Metagenics) Metagenics delivers on its commitment of providing safe, effective, and high quality products.

Metagenics is involved in the most exciting and promising research in our history. Our research will deliver new products for nutritional management of conditions, such as osteoarthritis, osteoporosis, heart disease, insulin resistance and diabetes, estrogen imbalances in women and men, and chronic gastrointestinal disorders.

Jeffrey S. Bland, PhD, FACN
President and Chief Science Officer
Metagenics, Inc.